Search results for: Innovation Policy Prize
Filter search results
Pharmaceuticals in Developing Countries
1 July 1983
The Office of Health Economics has recently widened its scope to take a special interest in the health care problems of the Poor World, with particular reference to. the role…
Consumer Movement, Health, and the Pharmaceutical Industry
1 January 1983
In his Inquiry into the Nature and Causes of the Wealth of Nations, which was first published in 1776, Adam Smith placed special emphasis on the assertion that the ultimate…
Future for Pharmaceuticals: the Potential; the Pattern and the Problems
1 June 1983
Britain has very little to be proud of on the industrial front in the 1980s. Many of its traditional industries — the so-called ‘smokestack industries’ — are in decline. It…
Second Pharmacological Revolution
1 July 1983
The published proceedings of the symposium held at the Royal College of Physicians, London in September 1982 by the Office of Health Economics to mark the 20th Anniversary of OHE….
Patterns of European Diagnoses and Prescribing
1 January 1984
In the summer of 1982 the Medico-Pharmaceutical Forum held a meeting on ‘Disparities in European Medicine’. The aim was to compare and contrast the various aspects of health and medical…
Crisis in Research
1 April 1986
In 1983 almost £6.6 billion was spent on research and development in the United Kingdom. This sum was five times that recorded in 1972 and even when account is taken…
Holes in Therapy
1 July 1989
The text of a lecture delivered at the Conference of the European Federation of Pharmaceutical Industry Associations in Paris in June 1989… The text of a lecture delivered at the…
Value of the Pharmaceutical Industry to the UK Economy
1 June 1995
Although there is widespread agreement about the important role the pharmaceutical industry plays in the U K economy, there is no easily available source presenting the chief figures in a…
Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry
1 October 1997
…UK privatised utility regulation and competition policy. The experience of other major European countries in regulating pharmaceuticals is also considered. It is structured as follows: • Section 2 outlines the…